This content is machine translated Small cell lung carcinoma Durvalumab approved as first immunotherapy for patients with LS-SCLC Durvalumab has been approved as a monotherapy in Switzerland for the treatment of adult patients with unresectable small cell lung cancer (LS-SCLC, limited-stage small cell lung cancer) whose disease has...…
View Post 3 min This content is machine translated Acute myeloid leukemia QuANTUM wild-type Phase 3 trial for patients with FLT3-ITD-negative AML started Acute myeloid leukemia (AML) is one of the most common forms of leukemia in adults. To date, there are no approved FLT3 inhibitors for patients with FLT3-ITD-negative AML, although sustained...…
View Post 3 min This content is machine translated Lennox-Gastaut syndrome Unmet need with a significant burden of disease New data presented at the 15th European Epilepsy Congress show long delays in the diagnosis of Lennox-Gastaut syndrome (LGS) in Europe and a significant burden of disease due to seizure…
View Post 3 min This content is machine translated Epilepsy in childhood Modern therapy management is more than just seizure control Lennox-Gastaut syndrome and Dravet syndrome are rare and severe developmental and epileptic encephalopathies with onset in infancy or early childhood. In addition to the seizures, comorbidities often occur, which represent…
View Post 4 min This content is machine translated Varicella zoster virus Adjuvanted subunit vaccine offers long-lasting protection The results of ZOSTER-049 – an extension of two Phase III clinical trials – show that the adjuvanted recombinant zoster vaccine (RZV) can provide protection against shingles for a decade…
View Post 5 min This content is machine translated Phytotherapy Ginkgo special extract with patented production process Ginkgo biloba (G. biloba) is one of the best-studied medicinal plants in phytotherapy. Extracts from G. biloba leavesare used in medicine to treat cognitive impairment, dizziness and tinnitus. In a…
View Post 5 min This content is machine translated Influenza season 2023/24 Current protection options for particularly vulnerable people The flu is unpredictable and spreads quickly [1]. This makes it all the more important that people at risk in particular protect themselves against infection [2]. A high-dose influenza vaccine…
View Post 3 min This content is machine translated Type 2 diabetes: PIONEER REAL Switzerland study Semaglutide in oral form convinces in everyday practice In the non-interventional PIONEER REAL Switzerland study, adult type 2 diabetics treated with oral semaglutide as part of routine clinical care achieved clinically significant improvement in glycemic control with no…
View Post 5 min This content is machine translated Antiviral therapies against COVID-19 Current recommendation for high-risk patients! The wave of colds is already well underway. The number of coronavirus infections is rising steadily again – and with it the number of infected people from potential risk groups.…
View Post 3 min This content is machine translated Respiratory syncytial virus (RSV) New vaccine candidate receives CHMP recommendation The positive opinion of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) is based on Phase III study data showing statistically significant and clinically meaningful…
View Post 3 min This content is machine translated Cutaneous T-cell lymphoma (CTCL) First targeted antibody approved for CTCL patients with MF or SS The approval of the anti-CCR4 antibody mogamulizumab provides patients with cutaneous T-cell lymphoma (CTCL) of the mycosis fungoides (MF) and Sézary syndrome (SS) subtypes with an effective non-chemotherapeutic intervention for…
